Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
0.4050
-0.0060
(-1.46%)
As of 4:31:48 PM GMT+1. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-25,041
-32,023
-39,026
-30,259
-17,705
Investing Cash Flow
33,853
38,412
49,949
-143,118
-1,403
Financing Cash Flow
-1,024
-11,173
-287
163,940
35,453
End Cash Position
19,131
13,011
17,795
7,159
16,596
Interest Paid Supplemental Data
--
--
--
57
12
Capital Expenditure
-146
-180
-321
-2,026
-1,206
Issuance of Capital Stock
--
--
--
164,086
37,012
Issuance of Debt
--
--
--
--
567
Repayment of Debt
-800
-761
-629
-255
-41
Repurchase of Capital Stock
-252
-10,384
--
--
--
Free Cash Flow
-25,187
-32,203
-39,347
-32,285
-18,911
12/31/2020 - 2/15/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
8AW0.SG Ocean Biomedical Inc
0.0915
+0.55%
51S.MU Cynata Therapeutics Ltd
0.1640
0.00%
0M4.BE Mersana Therapeutics Inc
0.4714
-1.57%
0M4.SG Mersana Therapeutics Inc
0.4769
-1.22%
0M4.F Mersana Therapeutics, Inc.
0.3900
-9.87%
0M4.MU Mersana Therapeutics Inc
0.4915
-5.15%
0M4.DU Mersana Therapeutics Inc
0.4690
-5.67%
8AW0.F Ocean Biomedical, Inc.
0.0860
-3.37%
BLRX.TA BioLineRx Ltd.
2.0000
-4.76%
WINTW WINDTREE THERAPEUTICS INC C/WTS
0.0090
+462.50%